Exploring an Expanding AML Therapeutic Armamentarium: Expert Guidance to Optimize Outcomes

Gain multidisciplinary expert insights on the latest approved AML therapies to improve the care of patients with newly diagnosed or relapsed/refractory disease with these downloadable slides and on-demand Webcast of a CCO/NCCN Webinar.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

Supporters

Supported by educational grants from

AbbVie Inc.

Astellas Pharma US

Pfizer, Inc.

Servier Pharmaceuticals